eftilagimod alpha,pembrolizumab
immutep,merck
['tacti-002']
great #tweetorial on #asco22 data on tacti-002, summary 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows https://t.co/dsiuV460lQ, Views my own